Annual Operating Profit
-$15.77 M
+$24.83 M+61.16%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual operating income is -$15.77 million, with the most recent change of +$24.83 million (+61.16%) on December 1, 2023.
- During the last 3 years, ORMP annual operating profit has fallen by -$8.21 million (-108.56%).
- ORMP annual operating profit is now -35098.66% below its all-time high of -$44.80 thousand, reached on August 31, 2005.
Performance
ORMP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$3.09 M
+$46.00 K+1.47%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly operating income is -$3.09 million, with the most recent change of +$46.00 thousand (+1.47%) on September 1, 2024.
- Over the past year, ORMP quarterly operating profit has increased by +$788.00 thousand (+20.32%).
- ORMP quarterly operating profit is now -192962.50% below its all-time high of -$1600.00, reached on February 28, 2006.
Performance
ORMP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$13.06 M
-$196.00 K-1.52%
September 1, 2024
Summary
- As of February 7, 2025, ORMP TTM operating income is -$13.06 million, with the most recent change of -$196.00 thousand (-1.52%) on September 1, 2024.
- Over the past year, ORMP TTM operating profit has increased by +$2.71 million (+17.16%).
- ORMP TTM operating profit is now -261160.00% below its all-time high of -$5000.00, reached on November 30, 2005.
Performance
ORMP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ORMP Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.2% | +20.3% | +17.2% |
| 3 y3 years | -108.6% | +72.9% | +65.8% |
| 5 y5 years | -7.8% | -31.7% | -5.2% |
ORMP Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.9% | +61.2% | -6.8% | +72.9% | -1.5% | +67.8% |
| 5 y | 5-year | -108.6% | +61.2% | -35.8% | +72.9% | -17.8% | +67.8% |
| alltime | all time | <-9999.0% | +61.2% | <-9999.0% | +72.9% | <-9999.0% | +67.8% |
Oramed Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.09 M(-1.5%) | -$13.06 M(+1.5%) |
| Jun 2024 | - | -$3.13 M(+5.8%) | -$12.87 M(-4.9%) |
| Mar 2024 | - | -$2.96 M(-23.6%) | -$13.52 M(-14.2%) |
| Dec 2023 | -$15.77 M(-61.2%) | -$3.88 M(+34.0%) | -$15.77 M(-27.1%) |
| Sep 2023 | - | -$2.89 M(-23.7%) | -$21.63 M(-19.7%) |
| Jun 2023 | - | -$3.79 M(-27.2%) | -$26.93 M(-22.1%) |
| Mar 2023 | - | -$5.21 M(-46.5%) | -$34.55 M(-14.9%) |
| Dec 2022 | -$40.60 M(+229.4%) | -$9.74 M(+18.9%) | -$40.60 M(+4.3%) |
| Sep 2022 | - | -$8.19 M(-28.3%) | -$38.92 M(+2.0%) |
| Jun 2022 | - | -$11.42 M(+1.5%) | -$38.14 M(+16.1%) |
| Mar 2022 | - | -$11.25 M(+39.6%) | -$32.84 M(+24.1%) |
| Dec 2021 | -$12.33 M(-49.1%) | - | - |
| Nov 2021 | - | -$8.06 M(+8.8%) | -$26.46 M(+9.2%) |
| Aug 2021 | -$24.22 M(+220.4%) | -$7.41 M(+21.1%) | -$24.22 M(+22.2%) |
| May 2021 | - | -$6.12 M(+25.7%) | -$19.83 M(+24.0%) |
| Feb 2021 | - | -$4.87 M(-16.5%) | -$15.99 M(+5.5%) |
| Dec 2020 | -$7.56 M(-35.7%) | - | - |
| Nov 2020 | - | -$5.83 M(+93.1%) | -$15.15 M(+28.9%) |
| Aug 2020 | -$11.76 M(-19.6%) | -$3.02 M(+32.7%) | -$11.76 M(+6.1%) |
| May 2020 | - | -$2.27 M(-43.7%) | -$11.09 M(-14.0%) |
| Feb 2020 | - | -$4.04 M(+66.2%) | -$12.89 M(+3.8%) |
| Nov 2019 | - | -$2.43 M(+3.6%) | -$12.42 M(-15.1%) |
| Aug 2019 | -$14.63 M(+8.2%) | -$2.35 M(-42.5%) | -$14.63 M(-5.2%) |
| May 2019 | - | -$4.08 M(+14.3%) | -$15.44 M(-2.9%) |
| Feb 2019 | - | -$3.57 M(-23.1%) | -$15.89 M(+3.0%) |
| Nov 2018 | - | -$4.64 M(+47.3%) | -$15.44 M(+14.1%) |
| Aug 2018 | -$13.53 M(+25.6%) | -$3.15 M(-30.5%) | -$13.53 M(+2.2%) |
| May 2018 | - | -$4.53 M(+45.7%) | -$13.23 M(+21.9%) |
| Feb 2018 | - | -$3.11 M(+13.9%) | -$10.85 M(-2.3%) |
| Nov 2017 | - | -$2.73 M(-4.2%) | -$11.11 M(+3.1%) |
| Aug 2017 | -$10.77 M(+7.6%) | -$2.85 M(+32.4%) | -$10.77 M(-6.0%) |
| May 2017 | - | -$2.15 M(-36.0%) | -$11.46 M(+0.4%) |
| Feb 2017 | - | -$3.37 M(+40.3%) | -$11.41 M(+14.6%) |
| Nov 2016 | - | -$2.40 M(-32.2%) | -$9.96 M(-0.5%) |
| Aug 2016 | -$10.01 M(+35.6%) | -$3.54 M(+67.7%) | -$10.01 M(+15.8%) |
| May 2016 | - | -$2.11 M(+10.4%) | -$8.64 M(+5.8%) |
| Feb 2016 | - | -$1.91 M(-21.9%) | -$8.17 M(+3.0%) |
| Nov 2015 | - | -$2.45 M(+12.7%) | -$7.93 M(+7.4%) |
| Aug 2015 | -$7.38 M | -$2.17 M(+33.0%) | -$7.38 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2015 | - | -$1.63 M(-2.4%) | -$6.86 M(-3.8%) |
| Feb 2015 | - | -$1.67 M(-12.0%) | -$7.13 M(+7.3%) |
| Nov 2014 | - | -$1.90 M(+15.3%) | -$6.64 M(+12.4%) |
| Aug 2014 | -$5.91 M(+37.2%) | -$1.65 M(-13.3%) | -$5.91 M(+12.8%) |
| May 2014 | - | -$1.90 M(+60.5%) | -$5.23 M(+12.2%) |
| Feb 2014 | - | -$1.19 M(+1.5%) | -$4.67 M(-1.6%) |
| Nov 2013 | - | -$1.17 M(+19.5%) | -$4.74 M(+10.1%) |
| Aug 2013 | -$4.30 M(+49.2%) | -$977.70 K(-26.7%) | -$4.30 M(+0.9%) |
| May 2013 | - | -$1.33 M(+5.9%) | -$4.26 M(+22.9%) |
| Feb 2013 | - | -$1.26 M(+72.2%) | -$3.47 M(+10.1%) |
| Nov 2012 | - | -$731.80 K(-21.9%) | -$3.15 M(+9.2%) |
| Aug 2012 | -$2.88 M(+18.4%) | -$937.30 K(+73.4%) | -$2.88 M(+13.5%) |
| May 2012 | - | -$540.40 K(-42.5%) | -$2.54 M(-2.0%) |
| Feb 2012 | - | -$940.40 K(+101.8%) | -$2.59 M(+12.8%) |
| Nov 2011 | - | -$465.90 K(-21.7%) | -$2.30 M(-5.6%) |
| Aug 2011 | -$2.44 M(-18.1%) | -$595.00 K(+0.6%) | -$2.44 M(-18.8%) |
| May 2011 | - | -$591.50 K(-8.6%) | -$3.00 M(-6.7%) |
| Feb 2011 | - | -$647.20 K(+7.6%) | -$3.21 M(+8.6%) |
| Nov 2010 | - | -$601.60 K(-48.0%) | -$2.96 M(-0.5%) |
| Aug 2010 | -$2.97 M(+6.8%) | -$1.16 M(+43.6%) | -$2.97 M(+33.9%) |
| May 2010 | - | -$806.00 K(+105.7%) | -$2.22 M(+14.1%) |
| Feb 2010 | - | -$391.90 K(-36.5%) | -$1.95 M(-11.6%) |
| Nov 2009 | - | -$617.50 K(+52.9%) | -$2.20 M(-21.0%) |
| Aug 2009 | -$2.78 M(+3.9%) | -$403.80 K(-24.1%) | -$2.78 M(-20.2%) |
| May 2009 | - | -$531.80 K(-17.7%) | -$3.49 M(-8.2%) |
| Feb 2009 | - | -$646.50 K(-46.2%) | -$3.80 M(+8.0%) |
| Nov 2008 | - | -$1.20 M(+8.4%) | -$3.52 M(+31.4%) |
| Aug 2008 | -$2.68 M(-14.4%) | -$1.11 M(+31.2%) | -$2.68 M(-34.1%) |
| May 2008 | - | -$845.00 K(+132.1%) | -$4.06 M(+15.7%) |
| Feb 2008 | - | -$364.10 K(+0.9%) | -$3.51 M(+2.8%) |
| Nov 2007 | - | -$361.00 K(-85.5%) | -$3.42 M(+9.1%) |
| Aug 2007 | -$3.13 M(+658.5%) | -$2.49 M(+746.2%) | -$3.13 M(+241.3%) |
| May 2007 | - | -$294.60 K(+9.8%) | -$917.70 K(+22.4%) |
| Feb 2007 | - | -$268.30 K(+252.6%) | -$750.00 K(+55.2%) |
| Nov 2006 | - | -$76.10 K(-72.7%) | -$483.30 K(+17.2%) |
| Aug 2006 | -$412.90 K(+821.7%) | -$278.70 K(+119.6%) | -$412.20 K(+208.8%) |
| May 2006 | - | -$126.90 K(+7831.3%) | -$133.50 K(+1922.7%) |
| Feb 2006 | - | -$1600.00(-68.0%) | -$6600.00(+32.0%) |
| Nov 2005 | - | -$5000.00 | -$5000.00 |
| Aug 2005 | -$44.80 K | - | - |
FAQ
- What is Oramed Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual operating profit year-on-year change?
- What is Oramed Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly operating profit year-on-year change?
- What is Oramed Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals TTM operating profit year-on-year change?
What is Oramed Pharmaceuticals annual operating income?
The current annual operating profit of ORMP is -$15.77 M
What is the all time high annual operating profit for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual operating income is -$44.80 K
What is Oramed Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ORMP annual operating income has changed by +$24.83 M (+61.16%)
What is Oramed Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ORMP is -$3.09 M
What is the all time high quarterly operating profit for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly operating income is -$1600.00
What is Oramed Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ORMP quarterly operating income has changed by +$788.00 K (+20.32%)
What is Oramed Pharmaceuticals TTM operating income?
The current TTM operating profit of ORMP is -$13.06 M
What is the all time high TTM operating profit for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high TTM operating income is -$5000.00
What is Oramed Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ORMP TTM operating income has changed by +$2.71 M (+17.16%)